By Nancy Lapid Jan 22 (Reuters) - Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight ...

New research suggests that many people who stop using GLP-1 drugs like Ozempic maintain their weight loss, countering previous studies.

By Bhanvi Satija and Maggie Fick LONDON, Jan 16 (Reuters) - Novo Nordisk's Wegovy weight-loss pill has made an encouraging ...

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...

Many people who use these medications don’t want to stay on them long term. But research has repeatedly shown that quitting ...

Jetset Select unveils the top global luxury hotspots for 2026 based on industry data and rising trends. Affluent ...

About half (53%) of Americans say they hear or read about Ozempic, Wegovy and similar drugs extremely or very often.

Background Antifibrotic (AF) therapy has been shown to potentially reduce the risk of lung cancer (LC) in patients with ...

A simple change in how primary care clinics approach weight management is delivering big public health wins. PATHWEIGH lets ...

Research has shown that people who stop taking GLP-1 drugs, such as Ozempic and Wegovy, typically experience weight regain ...

Researchers looked at birth weight, an important predictor of long-term health, in 11 million babies born in the United ...

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility ...